Senior Clinical Trial ManagerPrecigen, Inc. Germantown, Maryland, USAGermantown, MD, United States
Disclosure information not submitted.
PRGN-2012, a novel HPV-Targeted Immuno-Activator, induces complete and durable responses in recurrent respiratory papillomatosis patients
Sunday, October 12, 20258:12 AM - 8:18 AM EDT